Enovix Corporation (NASDAQ:ENVX) Given Consensus Rating of “Hold” by Brokerages

Enovix Corporation (NASDAQ:ENVX) has been assigned an average recommendation of “Hold” from the ten ratings firms that are covering the company, MarketBeat reports. Two investment analysts have rated the stock with a sell rating, two have given a hold rating and six have given a buy rating to the company. The average 12 month price target among analysts that have issued ratings on the stock in the last year is $12.50.

A number of research firms recently commented on ENVX. Oppenheimer reduced their price target on Enovix from $24.00 to $21.00 and set an “outperform” rating for the company in a report on Thursday, May 14th. JPMorgan Chase & Co. downgraded Enovix from a “neutral” rating to an “underweight” rating in a research report on Wednesday, May 6th. Wall Street Zen upgraded Enovix from a “strong sell” rating to a “sell” rating in a research note on Saturday, May 16th. Benchmark cut their price objective on Enovix from $25.00 to $15.00 and set a “buy” rating for the company in a research report on Thursday, May 14th. Finally, Craig Hallum reduced their target price on Enovix from $10.00 to $8.00 and set a “buy” rating for the company in a research note on Thursday, May 14th.

Enovix Stock Performance

Shares of ENVX stock opened at $4.29 on Thursday. The stock has a market cap of $935.86 million, a P/E ratio of -5.17 and a beta of 2.32. The company has a debt-to-equity ratio of 2.14, a current ratio of 10.97 and a quick ratio of 10.65. The company has a fifty day moving average price of $5.83 and a two-hundred day moving average price of $6.01. Enovix has a one year low of $3.67 and a one year high of $14.21.

Enovix (NASDAQ:ENVX) last announced its quarterly earnings data on Wednesday, May 13th. The company reported ($0.14) EPS for the quarter, beating analysts’ consensus estimates of ($0.15) by $0.01. The company had revenue of $7.60 million during the quarter, compared to the consensus estimate of $6.95 million. Enovix had a negative net margin of 499.64% and a negative return on equity of 64.28%. The company’s quarterly revenue was up 49.1% on a year-over-year basis. During the same quarter last year, the firm posted ($0.15) EPS. Enovix has set its Q2 2026 guidance at -0.170–0.130 EPS. As a group, equities analysts predict that Enovix will post -0.79 EPS for the current year.

Institutional Investors Weigh In On Enovix

Hedge funds have recently added to or reduced their stakes in the business. Caitong International Asset Management Co. Ltd acquired a new position in shares of Enovix in the fourth quarter valued at $30,000. Parallel Advisors LLC raised its position in shares of Enovix by 51.9% in the third quarter. Parallel Advisors LLC now owns 3,926 shares of the company’s stock valued at $39,000 after purchasing an additional 1,342 shares during the period. CWM LLC lifted its stake in shares of Enovix by 95.4% during the 4th quarter. CWM LLC now owns 6,081 shares of the company’s stock worth $44,000 after buying an additional 2,969 shares during the last quarter. Calamos Advisors LLC acquired a new stake in shares of Enovix during the 1st quarter worth about $60,000. Finally, Gateway Wealth Partners LLC acquired a new stake in shares of Enovix during the 1st quarter worth about $68,000. Institutional investors and hedge funds own 50.92% of the company’s stock.

Enovix Company Profile

Enovix Corporation (NASDAQ: ENVX) develops and manufactures advanced lithium-ion battery cells with a patented three-dimensional silicon-anode architecture. The company’s core focus is on delivering high energy density, improved safety, and longer cycle life compared to conventional graphite-based cells. Enovix’s technology targets a range of applications, including consumer electronics, wearable devices, electric vehicles and stationary energy storage systems.

Founded in 2011 and headquartered in Fremont, California, Enovix has built pilot production capability and is scaling up manufacturing capacity to meet growing demand.